Hypertension
Showing NaN - NaN of 90
Diabetes, Type 2, Hypertension Trial in Puerto Rico, United States (Canagliflozin, Placebo)
Completed
- Diabetes Mellitus, Type 2
- Hypertension
- Canagliflozin
- Placebo
-
Birmingham, Alabama
- +56 more
Mar 2, 2017
Hypertension Trial in United States (lisinopril, carvedilol controlled release formulation)
Completed
- Hypertension
- lisinopril
- carvedilol controlled release formulation
-
Anniston, Alabama
- +150 more
Nov 3, 2016
Hypertension Trial in United States (olmesartan medoxomil, Olmesartan medoxomil plus Hydrochlorothiazide)
Completed
- Hypertension
- olmesartan medoxomil
- Olmesartan medoxomil plus Hydrochlorothiazide
-
Birmingham, Alabama
- +26 more
Sep 28, 2016
Hypertension Trial in Worldwide (olmesartan medoxomil, )
Completed
- Hypertension
- olmesartan medoxomil
- placebo
-
Birmingham, Alabama
- +64 more
May 26, 2016
Hypertension Trial in Worldwide (Investigational Therapy (Surround Sound), Sham Control)
Unknown status
- Hypertension
- Investigational Therapy (Surround Sound)
- Sham Control
-
Clayton, Australia
- +27 more
Jan 6, 2016
Hypertension Trial in Worldwide (Aliskiren (6.25/12.5/25 mg), Aliskiren (37.5/75/150 mg), Aliskiren (150/300/600 mg))
Completed
- Hypertension
- Aliskiren (6.25/12.5/25 mg)
- +2 more
-
Birmingham, Alabama
- +47 more
Sep 15, 2015
Hypertension, Diabetes Trial in United States (Placebo, Azilsartan medoxomil)
Terminated
- Hypertension
- Diabetes
- Placebo
- Azilsartan medoxomil
-
Birmingham, Alabama
- +67 more
Apr 20, 2015
Hypertension Trial in United Kingdom, United States (Azilsartan medoxomil (TAK-491))
Terminated
- Hypertension
- Azilsartan medoxomil (TAK-491)
-
Little Rock, Arkansas
- +7 more
Jun 26, 2014
Hypertension, Diabetes, Type 2 Trial in Worldwide (telmisartan combined with hydrochlorothiazide (80/12.5 mg), valsartan
Completed
- Hypertension
- Diabetes Mellitus, Type 2
- telmisartan combined with hydrochlorothiazide (80/12.5 mg)
- valsartan combined with hydrochlorothiazide (160/12.5mg)
-
Birmingham, Alabama
- +101 more
Nov 7, 2013
Hypertension Trial in United States (telmisartan 80 mg/hydrochlorothiazide 25 mg, valsartan 160 mg/hydrochlorothiazide 25 mg, )
Completed
- Hypertension
- telmisartan 80 mg/hydrochlorothiazide 25 mg
- +2 more
-
Birmingham, Alabama
- +99 more
Nov 4, 2013
Hypertension, Diabetes, Type 2 Trial in Worldwide (telmisartan, enalapril)
Completed
- Hypertension
- Diabetes Mellitus, Type 2
-
Frederiksberg C, Denmark
- +36 more
Oct 31, 2013
Hypertension Trial in United States (Nebivolol, Valsartan and Hydrochlorothiazide)
Completed
- Hypertension
- Nebivolol, Valsartan and Hydrochlorothiazide
-
Birmingham, Alabama
- +134 more
May 31, 2013
Hypertension Trial in Birmingham (Dietary Approaches to Stop Hypertension-The DASH diet, Intervention with no dietary component
Completed
- Hypertension
- Dietary Approaches to Stop Hypertension-The DASH diet
- Intervention with no dietary component - information regarding useful life skills
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Department of Nutrition Scie
Mar 15, 2013